Heroux Devtek Inc
TSX:HRX

Watchlist Manager
Heroux Devtek Inc Logo
Heroux Devtek Inc
TSX:HRX
Watchlist
Price: 31.78 CAD Market Closed
Market Cap: 1.1B CAD
Have any thoughts about
Heroux Devtek Inc?
Write Note

P/E
Price to Earnings

20.5
Current
20.7
Median
33
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
20.5
=
Market Cap
1.1B CAD
/
Net Income
52.2m CAD
All Countries
All Countries
Close
Earnings Growth P/E to Growth
CA
Heroux Devtek Inc
TSX:HRX
Average P/E: 31.4
20.5
98%
0.2
US
Raytheon Technologies Corp
NYSE:RTX
33
188%
0.2
US
RTX Corp
LSE:0R2N
32.8
188%
0.2
US
Boeing Co
NYSE:BA
Negative Multiple: -16.8 N/A N/A
NL
Airbus SE
PAR:AIR
37.2
82%
0.5
US
Lockheed Martin Corp
NYSE:LMT
17.3
3%
6.1
FR
Safran SA
PAR:SAF
53.8
24%
2.3
US
TransDigm Group Inc
NYSE:TDG
49.4
88%
0.6
US
General Dynamics Corp
NYSE:GD
20.1
50%
0.4
US
Northrop Grumman Corp
NYSE:NOC
28.9
112%
0.3
UK
Rolls-Royce Holdings PLC
LSE:RR
21
-12%
N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
19.4
2-Years Forward
P/E
16.4
3-Years Forward
P/E
14.1

See Also

Summary
HRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
HRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HRX stock valuation using valuation multiples.
Wall Street Estimates
HRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 211,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.